Dyadic International, Inc.
USD0.90
+0.02 (+1.82%)
CEO
Mark A. Emalfarb
IPO Date
2008-01-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.89
Prev. Close
$0.88
Day Low
$0.87
Day High
$0.93
52W Low
$0.65
52W High
$1.35
Market Cap
$0.03B
Volume
0.13M
| -8.8 |
| 31 Dec 2023 | FY | 31.8% | -234.4% | -115.6% | -82.7% | 0.02 | 3.58 | -6.8 |
| 31 Dec 2022 | FY | 27.5% | -332.2% | -87.8% | -71.0% | 0.00 | 5.48 | -3.6 |
| 31 Dec 2021 | FY | 19.1% | -543.7% | -71.1% | -61.4% | 0.00 | 8.22 | -9.6 |
| 31 Dec 2020 | FY | 11.0% | -582.1% | -32.8% | -31.0% | 0.00 | 18.32 | -15.8 |
| 31 Dec 2019 | FY | 13.2% | -494.2% | -23.2% | -22.2% | 0.00 | 22.44 | -16.8 |
| 31 Dec 2018 | FY | 20.7% | -439.4% | -13.4% | -13.1% | 0.00 | 50.31 | -9.2 |
| 31 Dec 2017 | FY | 10.3% | -281.6% | -4.3% | -4.2% | 0.00 | 64.53 | -19.0 |
| 31 Dec 2016 | FY | 12.9% | -608.7% | -6.3% | -6.1% | 0.00 | 57.04 | -16.8 |
| -4.9 |
| 30 Sept 2025 | Q3 | 78.1% | -169.7% | -75.8% | -16.9% | 1.94 | 2.85 | -5.2 |
| 30 Jun 2025 | Q2 | -32.4% | -387.0% | 338.6% | -22.0% | -9.56 | 2.02 | -4.2 |
| 31 Mar 2025 | Q1 | -62.6% | -1107.4% | -219.5% | -25.7% | 5.48 | 3.98 | -5.0 |
| 31 Dec 2024 | Q4 | 56.8% | -189.7% | -62.8% | -15.6% | 2.05 | 4.01 | -8.3 |
| 30 Sept 2024 | Q3 | 79.8% | -10.4% | -6.0% | -1.9% | 1.57 | 5.15 | -37.7 |
| 30 Jun 2024 | Q2 | 21.8% | -530.0% | -64.6% | -19.2% | 1.76 | 5.39 | -5.5 |
| 31 Mar 2024 | Q1 | 57.0% | -600.6% | -44.5% | -15.8% | 1.32 | 5.54 | -6.0 |
| 31 Dec 2023 | Q4 | 49.0% | -301.8% | -35.2% | -25.2% | 0.02 | 3.58 | -5.6 |